As depicted in Figure 1B, the frequency of KIR/NKG2A(+) Eomes(+) CD8(+) T cells was more than 2.5-fold lower in CML-CP patients (3.1% ± 0.7; n = 6) than in HDs (8.2% ± 0.9; n = 15). Here, KIR3DL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.